Abstract:Background. This clinicopathological study evaluated the utility of serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 as predictors of locoregional recurrence and long-term disease-free survival in patients with gastric cancer.Methods. During the period January 1989 to December 1994, 485 patients with primary gastric cancer were evaluated. Gastrectomies were performed in 434 patients. Prognostic factors were analyzed by the Kaplan-Meier method and multivariate analysis, using Cox regression.Results. Elevated serum CEA and CA19-9 levels were observed in 92 of the 485 patients (19.0%), and in 95 of the 435 patients (21.8%), respectively, and both markers were elevated in 29 of these 435 patients (6.7%). Elevated serum CEA and CA19-9 levels correlated well with lymph node metastasis, lymphatic invasion, vessel invasion, stage grouping, depth of invasion, and curability. Patients with elevated serum CEA levels were at significantly higher risk of having all recurrence factors than were those with normal serum CEA levels. Patients with elevated serum CA19-9 levels were at significantly higher risk of having peritoneal metastases and distant metastases than were those with normal serum CA19-9 levels. A significant difference in the cumulative survival curves of patients was demonstrated between those with elevated and those with normal serum CEA or CA19-9 levels, even for patients at the same disease stage (stage III). Patients with elevated levels of both markers had a significantly worse prognosis than patients in whom the levels of both markers were normal. In patients who underwent gastrectomy, elevated serum CEA levels either preoperatively or within 3 weeks after gastrectomy were associated with significantly worse prognosis than were normal levels. When the cutoff level of serum CEA was increased to 10 ng/ml, serum CEA, age, lymph node metastasis, and surgical stage grouping were selected as independent prognostic factors by multivariate analysis of 14 prognostic factors, using Cox regression.Conclusion. Serum CEA and CA19-9 levels provide additional prognostic information in patients with primary gastric cancer. In particular, an elevated serum CEA level provides additional prognostic information and is a useful indicator of curability in patients who undergo gastrectomy. Serum CEA level is an independent prognostic factor in patients with primary gastric cancer.

Cutoff Value of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Elevation Levels for Monitoring Recurrence in Patients with Resectable Gastric Adenocarcinoma

Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China.

CA19-9 is a significant prognostic marker of patients with stage III gastric cancer

Cmar_a_246566 2767..2775

Predictive value of preoperative and postoperative serum tumor markers CEA, CA19 9, and CA72 4 in the diagnosis of gastric cancer recurrence at different stages

Preoperative CA19-9: a Competitive Predictor of Recurrence in Patients with Colorectal Cancer Liver Metastases after Hepatectomy

High Expression Of Serum Carcinoembryonic Antigen (Cea) Associated With Poor Prognosis In Early Gastric Cancer: A Single-Center Retrospective Study

Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.

Raised carbohydrate antigen 19-9 levels detect recurrences and impacts overall and disease-free survival in radically resected gallbladder cancer: A simple surveillance marker?

Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer

Stage-Specific Value of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Serum Levels on Survival and Recurrence in Pancreatic Cancer: A Single Center Study and Meta-Analysis

Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer

Postoperative Carcinoembryonic Antigen (CEA) Levels Predict Outcomes after Resection of Colorectal Cancer in Patients with Normal Preoperative CEA Levels.

Prognostic Values of Preoperative and Postoperative CEA and CA19.9 Levels in Pancreatic Cancer

CA19‐9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy

Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer

Preoperative CEA Levels Are Supplementary to CA19-9 Levels in Predicting Prognosis in Patients with Resectable Intrahepatic Cholangiocarcinoma

Prognostic Significance of Pretreatment Serum Carcinoembryonic Antigen Levels in Gastric Cancer with Pathological Lymph Node-Negative: A Large Sample Single-Center Retrospective Study.

Postoperative Serum CEA and CA125 Levels Are Supplementary to Perioperative CA19-9 Levels in Predicting Operative Outcomes of Pancreatic Ductal Adenocarcinoma.

Prognostic Value of Preoperative Serum Tumor Markers in Gastric Cancer

Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study